"Our hope is that more patients will be diagnosed using AcuPebble, freeing up clinician time to focus on treatment ... sleep apnea that is small enough to be posted to patients and simple enough that ...

Sleep expert Dr. Abhay Sharma talks about how Zepbound is now approved by the FDA for the treatment of moderate to severe ...

Obstructive sleep apnea (OSA) is very common (15 per cent to 30 per cent of men in the United States and 10 per cent to 15 ...

The Let’s Talk Smiles podcast announces its upcoming episode on sleep-related health issues, featuring sleep expert and ...

Frequent nighttime urination, also known as nocturia in medical terms, is a serious health condition that is characterized by ...

Peer Support Could Help Millions With Sleep Apnea Slumber Easier ... New Guideline Provides Treatment Recommendations for Restless Legs Syndrome Nov. 13, 2024 — A new clinical practice guideline ...

Leerink Partners analyst Mike Kratky has maintained their neutral stance on INSP stock, giving a Hold rating on January 13.Stay Ahead of the ...

His condition is considered "quite serious" as he experiences pauses in his breathing 59 times an hour while he is asleep. The normal range is five times an hour.

Researchers from University of Tsukuba have identified significant discrepancies between subjective and objective assessments ...

Goldman Sachs initiated coverage on ResMed Inc (NYSE:RMD) with a "Buy" rating and a price target of A$48.9, driven by strong growth prospects in its continuous airway pressure (CPAP) therapy segment.